Evidence map›Paper›PMID 34638506›Full record

ArticleCancers2021

Aberrant Signaling Pathways in Sinonasal Intestinal-Type Adenocarcinoma.

Cristina Riobello, Paula Sánchez-Fernández, Virginia N Cabal, Rocío García-Marín, Laura Suárez-Fernández, Blanca Vivanco, Verónica Blanco-Lorenzo, César Álvarez Marcos, Fernando López, José Luis Llorente and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Cristina RiobelloDepartment of Head and Neck Oncology, Instituto de Investigación Sanitaria del Principado de Asturias, 33011 Oviedo, Spain.
Paula Sánchez-FernándezDepartment of Otolaryngology, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.
Virginia N CabalDepartment of Head and Neck Oncology, Instituto de Investigación Sanitaria del Principado de Asturias, 33011 Oviedo, Spain.ORCID 0000-0002-4490-5747
Rocío García-MarínDepartment of Head and Neck Oncology, Instituto de Investigación Sanitaria del Principado de Asturias, 33011 Oviedo, Spain.ORCID 0000-0003-0331-2002
Laura Suárez-FernándezDepartment of Head and Neck Oncology, Instituto de Investigación Sanitaria del Principado de Asturias, 33011 Oviedo, Spain.
Blanca VivancoDepartment Pathology, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.
Verónica Blanco-LorenzoDepartment Pathology, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.
César Álvarez MarcosDepartment of Otolaryngology, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.
Fernando LópezDepartment of Otolaryngology, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.ORCID 0000-0001-7019-9746
José Luis LlorenteDepartment of Otolaryngology, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.
Mario A HermsenDepartment of Head and Neck Oncology, Instituto de Investigación Sanitaria del Principado de Asturias, 33011 Oviedo, Spain.
Hospital Universitario Central de Asturias · ESInstituto de Investigación Sanitaria del Principado de Asturias · ES

Funding

Ayudas a Grupos PCTI Principado de Asturias IDI2018/155Centro de Investigación Biomédica en Red de Cancer CB16/12/00390Fondos de Investigación Sanitaria PI13-646, PI15-1629 and PI17-763Fundación AECC CICPF16008HERM
6 · The paper itself

Abstract

Sinonasal intestinal-type adenocarcinoma (ITAC) is strongly related to occupational exposure to wood and leather dust, however, little is known on the genetic alterations involved in tumor development and progression. The aim of this study was to identify tumorigenic signaling pathways affected by gene mutations and their relation to clinical features. We applied whole exome sequencing of 120 cancer-related genes in 50 ITACs and analyzed the signaling activity of four specific pathways frequently affected by mutations. Genes involved in DNA damage response showed somatic mutations in 30% of cases, including four tumors that also harbored germline mutations. Genes in Wnt, MAPK and PI3K pathways harbored mutations in 20%, 20% and 24% of cases, respectively. Mutations and copy number gains in receptor tyrosine kinases possibly affecting MAPK and PI3K pathways occurred in 44% of cases. Expression of key pathway proteins showed no correlation to mutations in these pathways, except for nuclear β-catenin and APC/CTNNB1 mutation. No specific gene mutation, mutated pathway, nor pathway activity level showed correlation to clinical data or survival. In addition, a similar mutational profile was observed among histological subtypes. The wide spectrum of gene mutations suggests that ITAC is a genetically heterogeneous without specific characterizing gene mutations.

Indexed as

gene mutationsintestinal-type adenocarcinomanext generation sequencingsignaling pathwayssinonasal cancer

Identifiers

PMID34638506
PMCPMC8507674
OpenAlexW3202874885

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.